Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotr...
IRVINE, Calif., July 24, 2024--Edwards Lifesciences (NYSE: EW) today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation,...